SNBP Insider Trading Activity and SEC Form 4 Filings
SNBP insider trading summary
No open-market insider purchases or sales of Sun BioPharma, Inc. (SNBP) have been reported on SEC Form 4 in the past 12 months.
Latest SNBP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 10, 2020 | Jennifer K. Simpson | President and CEO | Buy | $3K (1,000 @ $2.74) |
| Sep 8, 2020 | Paul W. Schaffer | Director | Buy | $574 (225 @ $2.55) |
| Sep 4, 2020 | Paul W. Schaffer | Director | Buy | $62K (24,775 @ $2.51) |
| Sep 1, 2020 | Jennifer K. Simpson | President and CEO | Buy | $0 (2,424 @ $0.00) |
| Sep 1, 2020 | Arthur Fratamico | Director | Buy | $0 (2,424 @ $0.00) |
| Sep 1, 2020 | Michael T. Cullen | Exec. Chairman, Pres. & CEO | Buy | $0 (10,000 @ $0.00) |
| Sep 1, 2020 | Susan Horvath | V.P. of Finance & CFO | Buy | $0 (2,424 @ $0.00) |
| Jun 5, 2020 | Paul W. Schaffer | Director | Buy | $0 (10,000 @ $0.00) |
| Jun 5, 2020 | Susan Horvath | V.P. of Finance & CFO | Buy | $0 (2,500 @ $0.00) |
| May 22, 2020 | Michael T. Cullen | Exec. Chairman, Pres. & CEO | Buy | $0 (10,000 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.